Corbus Pharmaceuticals Holdings (CRBP) Assets Average (2014 - 2025)

Corbus Pharmaceuticals Holdings' Assets Average history runs 12 years deep, the most recent figure standing at $138.9 million for Q4 2025.

• In Q4 2025, Assets Average fell 13.23% year-over-year to $138.9 million; the TTM figure through Dec 2025 stood at $138.9 million (down 13.23% YoY), while the FY2025 annual figure was $162.0 million, up 75.98% from the prior year.
• Assets Average was $138.9 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $117.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $160.0 million in Q4 2024 to a low of $32.3 million in Q4 2023.
• Historically, Assets Average has averaged $103.7 million across 5 years, with a median of $115.5 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Assets Average plunged 53.94% in 2023, then jumped 395.78% in 2024.
• A 5-year view of Assets Average shows it stood at $113.7 million in 2021, then tumbled by 38.35% to $70.1 million in 2022, then sank by 53.94% to $32.3 million in 2023, then surged by 395.78% to $160.0 million in 2024, then fell by 13.23% to $138.9 million in 2025.
• The last three Assets Average figures came in at $138.9 million (Q4 2025), $117.3 million (Q3 2025), and $132.5 million (Q2 2025), per Business Quant data.